Table of Contents

Original Articles

• You have access

  ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines

  Yi Xie, Bing Wang, Liqing Du, Yan Wang, Chang Xu, Hong Zhang, Kaixue Wen, Qiang Liu and Takanori Katsube

  Cancer Biology & Medicine July 2022, 19 (7) 983-994; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0569
• You have access

  SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation

  Liao Wang, Yinghui Sun, Xijie Liu, Hongjuan Li, Chang Lu, Ronghui Yang, Chuanzhen Yang and Binghui Li

  Cancer Biology & Medicine July 2022, 19 (7) 995-1007; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0291
• You have access

  IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation

  Tingting Feng, Jing Wang, Kai Cheng, Qiqi Lu, Ru Zhao, Shiguan Wang, Qingyun Zhang, Luna Ge, Jihong Pan, Guanhua Song and Lin Wang

  Cancer Biology & Medicine July 2022, 19 (7) 1008-1028; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0583
• You have access

  Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma

  Duo Zuo, Yongzi Chen, Xinwei Zhang, Zhuozhi Wang, Wenna Jiang, Fan Tang, Runfen Cheng, Yi Sun, Lu Sun, Li Ren and Rui Liu

  Cancer Biology & Medicine July 2022, 19 (7) 1029-1046; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0516
• You have access

  Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages

  Yu Han, Yuming Yang, Qiuyang Sun, Bin Li, Caixia Yue, Yanlei Liu, Jesús M. de la Fuente and Daxiang Cui

  Cancer Biology & Medicine July 2022, 19 (7) 1047-1060; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0416
• You have access

  Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells

  Leyi Yao, Qian Zhao, Ding Yan, Ziying Lei, Yali Hao, Jinghong Chen, Qian Xue, Xiaofen Li, Qingtian Huang, Daolin Tang, Q. Ping Dou, Xin Chen and Jinbao Liu

  Cancer Biology & Medicine July 2022, 19 (7) 1061-1077; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0598
• You have access

  Microwave ablation vs. surgical resection for treatment naïve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years

  Jianping Dou, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Zhen Wang, Xiaoling Yu, Jie Yu and Ping Liang

  Cancer Biology & Medicine July 2022, 19 (7) 1078-1088; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0625
• You have access

  Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

  Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang

  Cancer Biology & Medicine July 2022, 19 (7) 1089-1099; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
• You have access

  Feasibility of sentinel lymph node biopsy omission after integration of ¹⁸F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial

  Junjie Li, Jingyi Cheng, Guangyu Liu, Yifeng Hou, Genghong Di, Benglong Yang, Yizhou Jiang, Liang Huang, Feilin Qu, Sheng Chen, Yan Wang, Keda Yu and Zhimin Shao

  Cancer Biology & Medicine July 2022, 19 (7) 1100-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0085